Australians are being urged to donate to life-saving prostate cancer research on Thursday, 20 November for Prostate Cancer ...

Company to invest in further research to strengthen clinical evidence ahead of medium-term U.S. launch with no further FDA approvals needed ...

RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinityTb-161 antitumor activity driven by the dual emission ...

Thousands of people are expected to celebrate Australia's annual Giving Day for prostate cancer research today, providing ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Liz Heggaton has become an "accidental advocate" for prostate cancer after her husband Craig took his own life while receiving treatment for the disease.

Prostate cancer is one of the most common cancers affecting men in Australia. According to the Australian Institute of Health and Welfare (AIHW) data, 29,000 new cases of prostate cancer are likely to ...

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Subscribe to our newsletter for the latest sci-tech ...

Movember highlights rising prostate and testicular cancer risks worldwide, urging men to screen early and support awareness ...